International Journal of Cardiovascular ResearchISSN: 2324-8602

Reach Us +1 850 900 2634

Research Article, Int J Cardiovasc Res Vol: 3 Issue: 1

Ischemia-Modified Albumin as a Marker of Myocardium and Skeletal Muscle Damage

Vladimir I Morozov1*, Michael I Kalinski2, Jason Jaggers2, Nikolay V Goncharov1 and Galina A Sakuta3
1Sechenov Institute of Evolutionary Physiology and Biochemistry of the Russian Academy of Sciences, Saint-Petersburg, Russia
2Murray State University, Murray, KY, USA
3Institute of Cytology of the Russian Academy of Sciences, Saint-Petersburg, Russia
Corresponding author : Vladimir I Morozov
Sechenov Institute of Evolutionary Physiology and Biochemistry of the Russian Academy of Sciences, Ave Torez 44, 194223 St-Petersburg, Russia
Tel: +7 (812) 552-7901; Fax: +7 (812) 552- 3012
E-mail: [email protected]
Received: December 13, 2013 Accepted: February 14, 2014 Published: February 25, 2014
Citation: Morozov VI, Kalinski MI, Jaggers J, Goncharov NV, Sakuta GA (2014) Ischemia-Modified Albumin as a Marker of Myocardium and Skeletal Muscle Damage. Int J Cardiovasc Res 3:1. doi:10.4172/2324-8602.1000157

Abstract

Ischemia-Modified Albumin as a Marker of Myocardium and Skeletal Muscle Damage

This is an overview of literature data on ischemia-modified albumin (IMA) and its potential as a marker of myocardium and skeletal muscle damage. Characteristics and properties of IMA are considered. IMA can be used as a nonspecific variable of ischemic conditions but IMA fails to differentiate between ischemic tissues. As a marker of ischemic conditions IMA may be used in combinations with other markers.

Keywords: Ischemia-modified albumin; Biomarker; Myocardium and Skeletal muscle damage

Track Your Manuscript

Share This Page

Media Partners